Anti-IgE-induced accumulation of leukocytes, mediators, and albumin in skin chamber fluid from healthy and atopic subjects

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 5, 1996, Pages 1151-1163

  Raud, Johan ^a,c   Halldén, Gunilla ^a   Roquet, Annika ^b   Van Hage Hamsten, Marianne ^c   Alkner, Ulf ^d   Hed, Jan ^a   Zetterström, Olle ^b   Dahlén, Sven Erik ^b   Hedqvist, Per ^c   Grönneberg, Reidar ^c  

^a From a Department of Physiology and Pharmacology   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

albumin extravasation; Allergic skin reaction; anti IgE; atopy; eosinophils; histamine; leukocytes; leukotriene B4; skin chamber; tryptase

Indexed keywords

ALBUMIN; HISTAMINE; IMMUNOGLOBULIN E; LEUKOTRIENE B4; TRYPTASE;

ACUTE PHASE RESPONSE; ADULT; ALLERGIC REACTION; ARTICLE; ATOPY; CLINICAL ARTICLE; CROSS LINKING; DRUG ACCUMULATION; FEMALE; HUMAN; HYPEREMIA; IMMEDIATE TYPE HYPERSENSITIVITY; LEUKOCYTE ACTIVATION; MALE; MAST CELL DEGRANULATION; MEDIATOR RELEASE; PRIORITY JOURNAL; SKIN MANIFESTATION;

EID: 0029885142     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70270-1     Document Type: Article

References (54)

1. Ishizaka T, Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy 1984;34: 188-235.
2. Gleich GJ. The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol 1982;70:160-9.
3. Zweiman B. Mediators of allergic inflammation in the skin. Clin Allergy 1988;18:419-33.
4. Togias A, Naclerio RM, Proud D, et al. Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol 1988;81:782-90.
5. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
6. Holgate S. Mediator and cytokine mechanisms in asthma. Thorax 1993;48:103-9.
7. Montefort S, Holgate ST, Howarth PH. Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur Respir J 1993;6:1044-54.
8. Weiss ME, Trent P, Fisher R, Norman PS, Waterbury WE, Adkinson NF Jr. Rabbit F(ab′)2 antihuman IgE is a universal skin test reagent in the evaluation of skin mast cell degranulation in vivo. J Allergy Clin Immunol 1989;83: 1040-8.
9. Grönneberg R, Zetterström O. Eosinophils in late cutaneous reactions [Letter]. Clin Exp Allergy 1991;21:377-8.
10. Gleich GJ. Why do allergic individuals accumulate more eosinophils at the site of an IgE-mediated reaction than do normal subjects? [Editorial]. Clin Exp Allergy 1990;20: 245-6.
11. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993;8:349-55.
12. Henocq E, Vargaftig BB. Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man. Lancet 1986;1:1378-9.
13. Henocq E, Rihoux JP. Does reversed-type anaphylaxis in healthy subjects mimic a real allergic reaction? Clin Exp Allergy 1990;20:269-72.
14. Eriksson NE. Allergy screening with Phadiatop and CAP Phadiatop in combination with a questionnaire in adults with asthma and rhinitis. Allergy 1990;45:285-92.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
16. Roquet A, Raud J, Halldén G, et al. Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopics. Allergy 1995;50: 414-20.
17. Fleekop PD, Atkins PC, von Allmen C, Valenzano MC, Shalit M, Zweiman B. Cellular inflammatory responses in human allergic skin reactions. J Allergy Clin Immunol 1987;80:140-6.
18. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:1519-26.
19. Thorell JI, Johansson BG. Enzymatic iodination of polypeptides to high activity. Biochim Biophys Acta 1971; 251:363-9.
20. Halldén G, Andersson U, Hed J, Johansson SGO. A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry. J Immunol Methods 1989;124:103-9.
21. Halldén G, Hed J. The FOG-mcthod - a new approach to detecting activated eosinophils. ACI News 1993;5:139-43.
22. Hed J, Halldén G. Counts of activated blood eosinophils for monitoring asthma. Allergy 1993;48(suppl 17):87-93.
23. Ihre E, Halldén G, Hed J, Zetterström O. Change in eosinophil expression of ECP and its relation to bronchial hyperresponsiveness after repeated inhalation of low doses of allergen. In: Ihre E, ed. Physiological changes and eosinophil activation in allergen induced asthma. Stockholm: Karolinska Institutet; 1993. Thesis.
24. Ohio H, Hitomi Y, Kambayashi H, Sato T, Maeda H. CD9 defined antigen (p24) is expressed on eosinophils but not on normal monocytes. In: McMichael A, ed. Leukocyte typing III. Oxford: Oxford University, 1987:731-2.
25. Rihoux J-P. Eosinophils in late cutaneous reactions [Letter]. Clin Exp Allergy 1991;21:378.
26. Zweiman B, Slott RI, Atkins PC. Factors in the tissue eosinophil responses in human immediate hypersensitivity reactions. Int Arch Allergy Appl Immunol 1976;52:48-52.
27. Tada T. Regulation of reaginic antibody formation in animals. Prog Allergy 1975;19:122-94.
28. Hanahoe TH. Mechanism of histamine release form rat isolated peritoneal mast cells by dextran: the role of immunoglobulin E. Agents Actions 1984;14:468-74.
29. Moser R, Fehr J, Bruijnzeel PL. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 1992;149:1432-8.
30. Warringa RA, Schweizer RC, Maikoe T, Kuijper PH, Bruijnzeel PL, Koendermann L. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992;7:631-6.
31. Bruijnzeel PL, Kuijper PH, Rihs S, Betz S, Warringa RA, Koenderman L. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionylleucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J Invest Dermatol 1993;100:137-42.
32. 4 - chemistry, biology and functional significance of eosinophil chemotactic leukotrienes in dermatology. Dermatologica 1989; 179(suppl 1):54-9.
33. 4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid. J Immunol 1991;147:2276-83.
34. Bray MA. Leukotrienes in inflammation. Agents Actions 1986;19:87-99.
35. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 1992;79:2952-9.
36. Bochner BS, Luscinskas FW, Oimbrone MA Jr, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991;173:1553-7.
37. Weg VB, Williams TJ, Lobb RR, Nourshargh S. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med 1993; 177:561-6.
38. Henocq E, Vargaftig BB. Skin eosinophilia in atopic patients. J Allergy Clin Immunol 1988;81:691-5.
39. Leiferman KM, Fujisawa T, Gray BH, Gleich GJ. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest 1990;62:579-89.
40. Zweiman B, Atkins PC, von Allmen C, Gleich GJ. Release of eosinophil granule proteins during IgE-mediated allergic skin reactions. J Allergy Clin Immunol 1991;87:984-92.
41. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976;58: 408-20.
42. Frew AJ, Kay AB. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol 1988;141:4158-64.
43. Charlesworth EN, Kagey-Sobotka A, Schleimer RP, Norman PS, Lichtenstein LM. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 1991;146:671-6.
44. Wedmore CV, Williams TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981;289:646-50.
45. Arfors K-E, Lundberg C, Lindbom L, Lundberg K, Beatty PG, Harlan JM. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood 1987;69:338-40.
46. Richerson HB, Rajtora DW, Penick GD, et al. Cutaneous and nasal allergic responses in ragweed hay fever: lack of clinical and histopathologic correlations with late phase reactions. J Allergy Clin Immunol 1979;64:67-77.
47. Nish WA, Charlesworth EN, Davis TL, et al. The effect of immunotherapy on the cutaneous late phase response to antigen. J Allergy Clin Immunol 1994;93:484-93.
48. Williams TJ. Interactions between prostaglandins, leukotrienes and other mediators of inflammation. Br Med Bull 1983;39:239-42.
49. Raud J, Lindbom L. Studies by intravital microscopy of basic inflammatory mechanisms and acute allergic inflammation. In: Brain S, ed. The handbook of immunopharmacology: immunopharmacology of the microcirculation. London: Academic Press, 1994:127-70.
50. Grönneberg R, Dahlén S-E. Interactions between histamine and prostanoids in IgE-dependent, late cutaneous reactions in man. J Allergy Clin Immunol 1990;85:843-52.
51. 4. Br J Pharmacol 1983;80:497-502.
52. 4 in skin-blister fluid after allergen testing in patients with late cutaneous reactions (LCR). Arch Dermatol Res 1985;277:400-1.
53. 4 act synergistically via a blood flow-independent mechanism to enhance microvascular plasma leakage. Acta Physiol Scand 1992;146:545-6.
54. Atkins PC, Kaplan AP, von Allmen C, Moskovitz A, Zweiman B. Activation of the coagulation pathway during ongoing allergic cutaneous reactions in humans. J Allergy Clin Immunol 1992;89:552-9.